OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Organization: Laboratory for Drug Discovery in neurodegeneration (LDDN)

1 Projects | 1 Researchers | $600,000 Invested

2018

Laboratory for Drug Discovery in neurodegeneration (LDDN)

Kevin Hodgetts, PhD

Novel Benzoxazines for the Treatment of Alzheimer's Disease

  • Funding Amount: $600,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Neuroinflammation
  • Status: Closed